Cyllene Therapeutics Expands Leadership Team to Support Corporate Growth and Clinical Product Development
Go back to Cyllene Therapeutics Expands Leadership Team to Support Corporate Growth and Clinical Product Development| (NASDAQ: NKTX) | Delayed: 3.23 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $3.23 | 52 Week High | $ | |||
| Open | $3.23 | 52 Week Low | $ | |||
| Day High | $3.23 | P/E | N/A | |||
| Day Low | $3.23 | EPS | $ | |||
| Volume | 826 | |||||

